Gene therapy for SCID--a complication after remarkable progress.
Publication
, Journal Article
Buckley, RH
Published in: Lancet
October 19, 2002
Duke Scholars
Published In
Lancet
DOI
ISSN
0140-6736
Publication Date
October 19, 2002
Volume
360
Issue
9341
Start / End Page
1185 / 1186
Location
England
Related Subject Headings
- Severe Combined Immunodeficiency
- Retroviridae
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Mutagenesis, Insertional
- Infant
- Humans
- Hematopoietic Stem Cell Transplantation
- Genetic Vectors
- Genetic Therapy
- General & Internal Medicine
Citation
APA
Chicago
ICMJE
MLA
NLM
Buckley, R. H. (2002). Gene therapy for SCID--a complication after remarkable progress. Lancet, 360(9341), 1185–1186. https://doi.org/10.1016/S0140-6736(02)11290-6
Buckley, Rebecca H. “Gene therapy for SCID--a complication after remarkable progress.” Lancet 360, no. 9341 (October 19, 2002): 1185–86. https://doi.org/10.1016/S0140-6736(02)11290-6.
Buckley RH. Gene therapy for SCID--a complication after remarkable progress. Lancet. 2002 Oct 19;360(9341):1185–6.
Buckley, Rebecca H. “Gene therapy for SCID--a complication after remarkable progress.” Lancet, vol. 360, no. 9341, Oct. 2002, pp. 1185–86. Pubmed, doi:10.1016/S0140-6736(02)11290-6.
Buckley RH. Gene therapy for SCID--a complication after remarkable progress. Lancet. 2002 Oct 19;360(9341):1185–1186.
Published In
Lancet
DOI
ISSN
0140-6736
Publication Date
October 19, 2002
Volume
360
Issue
9341
Start / End Page
1185 / 1186
Location
England
Related Subject Headings
- Severe Combined Immunodeficiency
- Retroviridae
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Mutagenesis, Insertional
- Infant
- Humans
- Hematopoietic Stem Cell Transplantation
- Genetic Vectors
- Genetic Therapy
- General & Internal Medicine